Abstract
Epilepsy is a common neurological disorder affecting all age groups We sought to assess the longitudinal effect of antiepileptic drug on serum 25-hydroxyvitamin D [25(OH)D], with recurrent attack of epileptic fits. The study consisted of two parallel, 1-year, prospective, randomized, dose-ranging trials conducted in two groups of ambulatory patients, for 46 patients based on clinical presentation of the patient together with confirmed diagnosis by EEG. The patients improved when maintenance dose of Vit D3 with daily taken to restore the normal level, with measurements for all patient 95 % of patient recovered from an epileptic fits with increase the level of Vit D3 to the normal value. In conclusions, majority of the patients should be treated with an escalating regimen of vitamin D, with doses varying between 400 and 15,000 IU/day.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
